NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/08/2025
Voltar para busca
Dado oficial do USPTO
ADPS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35, 42
Data de depósito
02/04/2024
Data de registro
12/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/08/2025
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
03
Localização do titular
Songpa-gu, Seoul, KR
Examinador
STEIN, JAMES W
Unidade examinadora
L70
Localização atual
INTENT TO USE SECTION
Descrição da marca
The mark consists of the stylized black letters "ADPS", with the left leg of "A" represented by a red blood drop and lower left parts of horizontal segments of "D" and "P" in red.
Titulares e representantes
Titulares
GeneCast Co., Ltd.
Representantes
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; medical diagnostic test strips for blood analysis; diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; chemical diagnostic reagents for medical use; in vitro diagnostic preparations for medical purposes for detecting cancer; indicators for medical diagnosismedical diagnostic reagents; reactants for medical diagnosismedical diagnostic reagents; pharmaceutical preparations for animals and humans for the treatment of cancer; pharmaceutical preparations for diagnosis of cancer; anti-cancer preparations
Classe 10
Apparatus for the treatment of cancer; medical measuring instruments for measuring tumors for cancer diagnosis; medical instrumentsbiopsy instruments; medical apparatus for detecting cancer; diagnostic measuring apparatus for medical usemedical diagnostic apparatus for analyzing and measuring tumors in the body; apparatus for carrying-out diagnostic tests for testing for cancers for medical purposes; diagnostic apparatus for medical purposes for testing cancers; apparatus for blood analysis for medical use; apparatus for blood monitoring for medical use; medical diagnostic apparatus for detecting cancer for use in the fields of clinical diagnosis; diagnosticexaminationmonitoring equipment in the nature of medical diagnostic apparatus for detecting cancer; testing instruments for medical diagnostic purposesapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; automatic analyzers for medical diagnosis for analyzing circulating tumor DNA; tools for medical diagnostics in the nature of medical diagnostic apparatus for detecting cancer; medical examination sheets in the nature of medical table sheets for examining tables and operating tables; apparatus for clinical diagnosis; diagnostic apparatus and instruments for medical purposes in the nature of medical diagnostic apparatus for detecting cancer; blood analysis apparatus for medical diagnosis purposes; in vitro diagnostic devices for medical purposes in the nature of medical diagnostic apparatus for detecting cancer
Classe 35
Wholesale store services featuring medical measuring instruments for cancer diagnosis; retail store services featuring medical measuring instruments for cancer diagnosis; wholesale store services featuring medical instruments; retail store services featuring medical instruments; retail store services featuring diagnostic reagents for medicinal use; retail store services featuring medical diagnostic test strips; wholesale store services featuring medical diagnostic test strips; retail store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring reagents for use in diagnostic tests for medical purposes; wholesale store services featuring diagnostic reagents for medicinal use; retail store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring testing instruments for medical diagnostic purposes; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for animals and humans; retail store services featuring pharmaceutical preparations for animals and humans; retail store services featuring apparatus for clinical diagnosis; wholesale store services featuring apparatus for clinical diagnosis; wholesale store services featuring blood analysis apparatus for diagnosis; retail store services featuring blood analysis apparatus for diagnosis
Classe 42
Research and development of technology for biotechnology; biotechnology servicesconsulting services in the field of biotechnology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; medical research laboratory services; medical research laboratory services for predicting disease; remote monitoring services for medical diagnostic devices; computer programming services for remote data management of medical diagnostic instruments; design of medical diagnostic apparatus and instruments; providing technological support services in the nature of troubleshooting in the nature of diagnosing problems with medical equipment regarding medical diagnostic instruments; providing computer software technical support services in the nature of diagnosing computer hardware and software problems in the field of medical diagnostics; computer programming services for remote control of medical diagnostic systems; engineering services in the medical technology field; blood testing for medical research purposesnot for medical diagnostic purposes; medical research; medical and scientific researchconducting clinical trials for others; clinical trials; blood analysis services; blood analysis services for scientific research purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
22/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
18/07/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/02/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
20/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2024
PUBO
PUBLISHED FOR OPPOSITION
24/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/12/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
26/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
15/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
15/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/10/2024
DOCK
ASSIGNED TO EXAMINER
15/10/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2024
NWAP
NEW APPLICATION ENTERED
02/04/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ADPS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.